Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
Studies reporting the effects of metabolic surgery, lifestyle intervention, and intensive insulin therapy for the remission of type 2 diabetes (T2DM) has been increasing, with fruitful results better conducted...
Source: BMC Endocrine Disorders - Category: Endocrinology Authors: Xue Yang, Zhiwei He, Li Yuan, Wenbin Huang, Doudou Li, Pingping Xiang, Yu Chen, Guofang Chen and Chao Liu Tags: Study Protocol Source Type: research
More News: Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Invokana | Study